82C.F Circassia Group Plc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.7300 EUR
Close of Nov 11, 2026
0.5840 0.8450
Market cap
EUR 296M
P/E
36.5x
P/B
3.76x
ROE
10.4%
Dividend yield
2.43%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 82C.F undervalued?

Graham number
Price0.7300
Graham value0.2955
Premium147.1%

82C.F trades 147.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Circassia Group Plc fundamental analysis

No fundamental analysis for Circassia Group Plc yet.

Circassia Group Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Circassia Group Plc

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc …

Full company profile